Advertisement

Salmonellosis

  • Herbert L. DuPont
  • Larry K. Pickering
Part of the Current Topics in Infectious Disease book series (CTID)

Abstract

Salmonella gastroenteritis is a common problem in all areas of the world, regardless of economic development. It has become an even greater problem in developed countries where mass production and distribution of food products have occurred. In contrast, endemicity of typhoid or enteric fever, generally the most serious form of Salmonella infection, is invariably related to reduced economic development and sanitation. Salmonella as the causative agent of intestinal infection is readily recovered by routine diagnostic microbiologic procedures. In this chapter, we will focus on the important aspects of human salmonellosis and will examine the differences between typhoid and nontyphoid disease.

Keywords

Typhoid Fever Chronic Granulomatous Disease Immunize Agent Typhoid Vaccine Salmonella Infection 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Edwards, P. R., Ewing, W. H. Identification of Enterobacteriaceae, 3rd ed. Burgess, Minneapolis, 1972.Google Scholar
  2. 2.
    Felix, A., Pitt, R. M. The pathogenic and immunogenic activities of Salmonella typhi in relation to its antigenic constituents. J. Hyg. (Cambridge) 49: 92–110, 1951.Google Scholar
  3. 3.
    Hornick, R. B., Greisman, S. E., Woodward, T. E., et al. Typhoid fever: Pathogenesis and immunologic control. N. Engl. J. Med. 283: 686–691, 739–746, 1970.Google Scholar
  4. 4.
    Germanier, R., Filer, E. Isolation and characterization of gal E mutant Ty 21a of Salmonella typhi. A candidate strain for a live, oral typhoid vaccine. J. Infect. Dis. 131: 553–558, 1975.PubMedGoogle Scholar
  5. 5.
    Speck, W. T., Wlodkowski, T. J., Rosenkranz, H. S. Decreased virulence of chlorate–resistant Salmonella typhimurium. J. Infect. Dis. 134: 90–92, 1976.PubMedGoogle Scholar
  6. 6.
    DuPont, H. L., Formal, S. B., Hornick, R. B., et al. Pathogenesis of Escherichia coli diarrhea. N. Engl. J. Med. 285: 1–9, 1971.PubMedGoogle Scholar
  7. 7.
    Giannella, R. A., Formal, S. B., Dammin, G. J., et al. Pathogenesis of salmonellosis: Studies of fluid secretion, mucosal invasion, and morphologic reaction in the rabbit ileum. J. Clin. Invest. 52: 441–453, 1973.PubMedGoogle Scholar
  8. 8.
    Taylor, J., Wilkins, M. P., The effect of Salmonella and Shigella on ligated loops of rabbit gut. Indian J. Med. Res. 49: 544–549, 1961.Google Scholar
  9. 9.
    Koupal, L. R., Deibel, R. H. Assay, characterization, and localization of an enterotoxin produced by Salmonella. Infect. Immun. 11: 14–22, 1975.PubMedGoogle Scholar
  10. 10.
    Sandefur, P. D., Peterson, J. W. Isolation of skin permeability factors from culture filtrates of Salmonella typhimurium. Infect. Immun. 14: 671–679, 1976.PubMedGoogle Scholar
  11. 11.
    Miller, R. M., Garbus, J., Hornick, R. B. Lack of enhanced oxygen consumption by polymorphonuclear leukocytes on phagocytosis of virulent Salmonella typhi. Science 175: 1010–1011, 1972.PubMedGoogle Scholar
  12. 12.
    D’Aoust, J. Y., Pivnick, H. Small infectious doses of salmonella. Lancet 1: 866, 1976.PubMedGoogle Scholar
  13. 13.
    Lipson, A., Infecting dose of salmonella (letter). Lancet 1: 969, 1976.PubMedGoogle Scholar
  14. 14.
    Waddell, W. R., Kunz, L. J. Association of Salmonella enteritis with operations on the stomach. N. Engl. J. Med. 255: 555–559, 1956.PubMedGoogle Scholar
  15. 15.
    Garrod, L. P. The susceptibility of different bacteria to destruction in the stomach (abstract). J. Pathol. Bacteriol. 45: 473–474, 1937.Google Scholar
  16. 16.
    Hook, E. W. Salmonellosis: Certain factors influencing the interaction of salmonella and the human host. Bull. N.Y. Acad. Med. 37: 499–512, 1961.PubMedGoogle Scholar
  17. 17.
    Nordbring, F. Contraction of salmonella gastroenteritis following previous operation on the stomach. Acta Med. Scand. 171: 783–790, 1962.Google Scholar
  18. 18.
    Giannella, R. A., Broitman, S. A., Zamcheck, N. Salmonella enteritis: I. Role of reduced gastric secretion in pathogenesis. Am. J. Dig. Dis. 16: 1000–1006, 1971.PubMedGoogle Scholar
  19. 19.
    Giannella, R. A., Broitman, S. A., Zamcheck, N. Salmonella enteritis: II. Fulminant diarrhea in and effects on the small intestine. Am. J. Dig. Dis. 16: 1007–1013, 1971.PubMedGoogle Scholar
  20. 20.
    Kent, T. H., Formal, S. B., LaBrec, E. H. Salmonella gastroenteritis in rhesus monkeys. Arch. Pathol. 82: 272–279, 1966.PubMedGoogle Scholar
  21. 21.
    Rout, W. R., Formal, S. B., Dammin, G. J., et al. Pathophysiology of salmonella diarrhea in the rhesus monkey: Intestinal transport, morphological, and bacteriological studies. Gastroenterology 67: 59–70, 1974.PubMedGoogle Scholar
  22. 22.
    Sprinz, H., Gangarosa, E. J., Williams, M., et al. Histopathology of the upper small intestines in typhoid fever: Biopsy study of experimental disease in man. Am. J. Dig. Dis. 11: 615–624, 1966.PubMedGoogle Scholar
  23. 23.
    Gaines, S., Sprinz, H., Tully, J. G., et al. Studies on infection and immunity in experimental typhoid fever: VII. The distribution of Salmonella typhi in chimpanzee tissue following oral challenge, and the relationship between the numbers of bacilli and morphologic lesions. J. Infect. Dis. 118: 293–306, 1968.PubMedGoogle Scholar
  24. 24.
    Gaines, S., Tully, J. G., Tigertt, W. D. Studies on infection and immunity in experimental typhoid fever: VIII. Intravenous and intra–lymph node challenge of chimpanzees with Salmonella typhi. J. Infect. Dis. 118: 393–401, 1968.PubMedGoogle Scholar
  25. 25.
    Edsall, G., Gaines, S., Landy, M., et al. Studies on infection and immunity in experimental typhoid fever: I. Typhoid fever in chimpanzees orally infected with Salmonella typhosa. J. Exp. Med. 112: 143–166, 1960.PubMedGoogle Scholar
  26. 26.
    Takeuchi, A. Penetration of intestinal epithelium by various microorganisms. Curr. Top. Pathol. 54: 1–27, 1971.Google Scholar
  27. 27.
    Harris, J. C., DuPont, H. L., Hornick, R. B. Fecal leukocytes in diarrheal illness. Ann. Intern. Med. 76: 697–703, 1972.PubMedGoogle Scholar
  28. 28.
    Aleekseev, P. A., Berman, M. I., Korneeva, E. P. Clinical and histological picture of Salmonella typhimurium infection in children. Zh. Mikrobiol. Epidemiol. Immunobiol. 31: 111–116, 1960.Google Scholar
  29. 29.
    Mandal, B. K., Mani, V. Colonic involvement in salmonellosis. Lancet 1: 887–888, 1976.PubMedGoogle Scholar
  30. 30.
    Radsel—Medvescek, A., Zargi, R., Acko, M., et al. Colonic involvement in salmonellosis (Letter). Lancet 1: 601, 1977.PubMedGoogle Scholar
  31. 31.
    Appelbaum, P. C., Scragg, J., Schonland, M. M. Colonic involvement in salmonellosis. Lancet 2: 102, 1976.Google Scholar
  32. 32.
    Greisman, S. E., Hornick, R. B., Wagner, H. N., et al. The integrity of the endotoxin tolerance mechanisms during typhoid fever in man. Trans. Assoc. Am. Physicians 80: 250–258, 1967.Google Scholar
  33. 33.
    Schroeder, S. A., Aserkoff, B., Brachman, P. S. Epidemic salmonellosis in hospitals and institutions: A five–year review. N. Engl. J. Med. 279: 674–678, 1968.Google Scholar
  34. 34.
    Cohen, M. L., Fontaine, R. E., Pollard, R. A., et al. An assessment of patient–related economic costs in an outbreak of salmonellosis. N. Engl. J. Med. 299: 459–460, 1978.PubMedGoogle Scholar
  35. 35.
    Wilder, A. N., MacCready, R. A. Isolation of salmonella from poultry, poultry products and poultry processing plants in Massachusetts. N. Engl. J. Med. 274: 1453–1460, 1966.PubMedGoogle Scholar
  36. 36.
    Cherubin, C. E., Fodor, T., Denmark, L., et al. The epidemiology of salmonellosis in New York City. Am. J. Epidemiol. 90: 112–125, 1969.PubMedGoogle Scholar
  37. 37.
    Greenburg, B., Kowalski, J. A., Klowden, M. J. Factors affecting the transmission of Salmonella by flies: Natural resistance to colonization and bacterial interference. Infect. Immun. 2: 800–809, 1970.Google Scholar
  38. 38.
    Feldman, R. E., Baine, W. B., Nitzkin, J. L., et al. Epidemiology of Salmonella typhi infection in a migrant labor camp in Dade County, Florida. J. Infect. Dis. 130: 335–342, 1974.PubMedGoogle Scholar
  39. 39.
    Annual Salmonella Surveillance Report. United States Department of Health, Education and Welfare, Public Health Service, National Communicable Disease Center, Atlanta, 1967.Google Scholar
  40. 40.
    Musher, D. M., Rubenstein, A. D. Permanent carriers of nontyphosa salmonellae. Arch. Intern. Med. 132: 869–872, 1973.PubMedGoogle Scholar
  41. 41.
    Aserkoff, B., Bennett, J. V. Effect of antibiotic therapy in acute salmonellosis on the fecal excretion of salmonellae. N. Engl. J. Med. 281: 636–640, 1969.PubMedGoogle Scholar
  42. 42.
    Watson, K. C. Intravascular Salmonella typhi as a manifestation of the carrier state. Lancet 2: 332–334, 1967.PubMedGoogle Scholar
  43. 43.
    Huckstep, R. L. Recent advances in the surgery of typhoid fever. Ann. R. Coll. Surg. Engl. 26: 207–230, 1960.PubMedGoogle Scholar
  44. 44.
    Woodward, T. E., Smadel, J. E. Management of typhoid fever and its complications. Ann. Intern. Med. 60: 144–157, 1964.PubMedGoogle Scholar
  45. 45.
    Archampong, E. Q. Operative treatment of typhoid perforation of the bowel. Br. Med. J. 3: 273–276, 1969.PubMedGoogle Scholar
  46. 46.
    Angorn, I. B., Pillay, S. P., Hegarty, M., et al. Typhoid perforation of the ileum: A therapeutic dilemma. S. Afr. Med. J. 49: 781–784, 1975.PubMedGoogle Scholar
  47. 47.
    Strate, R. W., Bannayan, G. A. Typhoid fever causing massive lower gastrointestinal hemorrhage: A reminder of things past. J. Am. Med. Assoc. 236: 1979–1980, 1976.Google Scholar
  48. 48.
    Ramachandran, S., Godfrey, J. J., Perera, M. V. F. Typhoid hepatitis. J. Am. Med. Assoc. 230: 236–240, 1974.Google Scholar
  49. 49.
    Faierman, D., Ross, F. A., Seckler, S. G. Typhoid fever complicated by hepatitis, nephritis, and thrombocytopenia. J. Am. Med. Assoc. 221: 60–61, 1972.Google Scholar
  50. 50.
    Sitprija, V., Pipatanagul, V., Boonpucknavig, V.Glomerulitis in typhoid fever. Ann. Intern. Med. 81: 210–213, 1974.Google Scholar
  51. 51.
    Rheingold, O. J., Greenwald, R. A., Hayes, P. J., et al. Myoglobinuria and renal failure associated with typhoid fever. J. Am. Med. Assoc. 238: 341, 1977.Google Scholar
  52. 52.
    Allen, N., Nomanbhoy, Y., Green, D., et al. Typhoid fever with consumption coagulopathy. J. Am. Med. Assoc. 208: 689–690, 1969.Google Scholar
  53. 53.
    Van Diem, L., Arnold, K. Typhoid fever with myocarditis. Am. J. Trop. Med. Hyg. 23: 218–221, 1974.Google Scholar
  54. 54.
    Rowland, H. A. K. The complications of typhoid fever. J. Trop. Med. Hyg. 64: 143–152, 1961.PubMedGoogle Scholar
  55. 55.
    Briem, H., Evengard, B., Jonsson, M. Reiter’s syndrome complicating Salmonella enteritidis infection. Lancet 2: 112, 1978.PubMedGoogle Scholar
  56. 56.
    Siasoco, R. E., Chen, C., Chang, T. Tuberculin reaction in typhoid fever. Ann. Intern. Med. 81: 400, 1974.PubMedGoogle Scholar
  57. 57.
    Baine, W. B., Gangarosa, E. J., Bennett, J. V., et al. Institutional salmonellosis. J. Infect. Dis. 128: 357–360, 1973.PubMedGoogle Scholar
  58. 58.
    McCall, C. E., Collins, R. N., Jones, D. B., et al. An interstate outbreak of salmonellosis traced to a contaminated food supplement. Am. J. Epidemiol. 84: 32–39, 1966.PubMedGoogle Scholar
  59. 59.
    Komarmy, L. E., Oxley, M. E., Brecher, G. Hospital–acquired salmonellosis traced to carmine dye capsules. N. Engl. J. Med. 276: 850–852, 1967.PubMedGoogle Scholar
  60. 60.
    Lang, D. J., Kunz, L. J., Martin, A. R., et al. Carmine as a source of nosocomial salmonellosis. N. Engl. J. Med. 276: 829–832, 1967.PubMedGoogle Scholar
  61. 61.
    Rhame, F. S., Root, R. K., MacLowry, J. D. Salmonella septicemia from platelet transfusions: Study of an outbreak traced to a hematogenous carrier of Salmonella cholerae–suis. Ann. Intern. Med. 78: 633–641, 1973.PubMedGoogle Scholar
  62. 62.
    Salmonella Surveillance Report No. 59. United States Department of Health, Education and Welfare, Public Health Service, National Communicable Disease Center, Atlanta, 1967, p. 8.Google Scholar
  63. 63.
    Ryder, R. W., Crosby–Ritchie, A., McDonough, B. Human milk contaminated with Salmonella kottbus: A cause of nosocomial illness in infants. J. Am. Med. Assoc. 238: 1533–1534, 1977.Google Scholar
  64. 64.
    Rubenstein, A. D., Fowler, R. N. Salmonellosis of the newborn with transmission by delivery room resuscitators. Am. J. Public Health 45: 1109–1114, 1955.Google Scholar
  65. 65.
    Edgar, W. M., Lacey, B. W. Infection with Salmonella heidelberg: An outbreak presumptively not foodborne. Lancet 1: 161–163, 1963.Google Scholar
  66. 66.
    Epstein, H. C., Hochwald, A., Ashe, R. Salmonella infections of the newborn infant. J. Pediatr. 38: 723–731, 1951.PubMedGoogle Scholar
  67. 67.
    Pearson, H. E., Grant, W. J. Presumed transmission of salmonella by sigmoidoscope. Calif. Med. 112: 23–25, 1970.PubMedGoogle Scholar
  68. 68.
    Watt, J., Wegman, M. E., Brown, O. W., et al. Salmonellosis in a premature nursery unaccompanied by diarrhea! disease. Pediatrics 22: 689–705, 1958.PubMedGoogle Scholar
  69. 69.
    Bate, J. G., James, U. Salmonella typhimurium infection dust–borne in a children’s ward. Lancet 2: 713–715, 1958.PubMedGoogle Scholar
  70. 70.
    Mushin, R. An outbreak of gastroenteritis due to Salmonella derby. J. Hyg. (Cambridge) 46: 151–157, 1948.Google Scholar
  71. 71.
    Szmuness, W. Infections hospitalières par Salmonella enteritidis chez les enfants. Rev. Hyg. Mid. Soc. 13: 531–548, 1965.Google Scholar
  72. 72.
    Sanders, E., Sweeney, F. J., Jr., Friedman, E. A. An outbreak of hospital–associated infections due to Salmonella derby. J. Am. Med. Assoc. 186: 984–986, 1963.Google Scholar
  73. 73.
    Hirsch, W., Sapiro–Hirsch, R., Berger, A. Salmonella edinburg infection in children: A protracted hospital epidemic due to a multiple–drug–resistant strain. Lancet 2: 828–830, 1965.PubMedGoogle Scholar
  74. 74.
    Leeder, F. S. An epidemic of Salmonella panama infections in infants. Ann. N.Y. Acad. Sci. 66: 54–60, 1956.PubMedGoogle Scholar
  75. 75.
    Abroms, I. F., Cochran, W. D., Holmes, L. B., et al. A Salmonella newport outbreak in a premature nursery with a 1–year follow–up: Effect of ampicillin following bacteriologic failure of response to kanamycin. Pediatrics 37: 616–623, 1966.PubMedGoogle Scholar
  76. 76.
    Szanton, V. L. Epidemic salmonellosis—a 30–month study of 80 cases of Salmonella oranienburg infection. Pediatrics 20: 794–808, 1957.PubMedGoogle Scholar
  77. 77.
    Cherubin, C. E., Neu, H. C., Imperato, P. J., et al. Septicemia with nontyphoid salmonella. Medicine 53: 365–376, 1974.PubMedGoogle Scholar
  78. 78.
    Black, P. H., Kunz, L. J., Swartz, M. N. Salmonellosis: A review of some unusual aspects. N. Engl. J. Med. 262:811–817, 864–870, 921–927, 1960.Google Scholar
  79. 79.
    Angrist, A., Molloy, M. Bacteriologic, clinical and pathological experience with 86 sporadic cases of salmonella infection. Am. J. Med. Sci. 212: 336–346, 1946.PubMedGoogle Scholar
  80. 80.
    Harvey, A. M. Salmonella suipestifer infection in human beings: Review of the literature and report of twenty–one new cases. Arch. Intern. Med. 59: 118–135, 1937.Google Scholar
  81. 81.
    Griffiths, P. W. W. Atypical cases of salmonellosis in hospital. Lancet 2: 958–960, 1961.PubMedGoogle Scholar
  82. 82.
    Kaye, D., Gill, F. A., Hook, E. W. Factors influencing host resistance to salmonella infections: The effects of hemolysis and erythrophagocytosis. Am. J. Med. Sci. 254: 205–215, 1967.PubMedGoogle Scholar
  83. 83.
    Bennett, I. L., Jr., Hook, E. W. Infectious diseases: Some aspects of salmonellosis. Annu. Rev. Med. 10: 1–20, 1959.Google Scholar
  84. 84.
    Anderson, T. R., Zimmerman, L. E. Relapsing fever in Korea: Clinicopathologic study of eleven fatal cases with special attention to association with Salmonella infections. Am. J. Pathol. 31: 1083–1109, 1955.PubMedGoogle Scholar
  85. 85.
    Ricketts, W. E. Intercurrent infections of Carrion’s disease observed in Peru. Am. J. Trop. Med. Hyg. 28: 437–451, 1948.PubMedGoogle Scholar
  86. 86.
    Hand, W. L., King, N. L. Serum opsonization of salmonella in sickle cell anemia. Am. J. Med. 64: 388–395, 1978.PubMedGoogle Scholar
  87. 87.
    Field, R., Overturf, G. D. Defective opsonization of salmonella lipopolysaccharide in sickle cell disease. Pediatr. Res. 12: 491, 1978.Google Scholar
  88. 88.
    Cooper, M. R., DeChatelet, L. R., McCall, C. E., et al. Complete deficiency of leukocyte glucose–6–phosphate dehydrogenase with defective bactericidal activity. J. Clin. Invest. 51: 769–778, 1972.PubMedGoogle Scholar
  89. 89.
    Iron and resistance to infection (editorial). Lancet 2: 325–326, 1974.Google Scholar
  90. 90.
    Rodey, G. E., Park, B. H., Windhorst, D. B., et al. Defective bactericidal activity of monocytes in fatal granulomatous disease. Blood 33: 813–820, 1969.PubMedGoogle Scholar
  91. 91.
    Davis, W. C., Huber, H., Douglas, S. D., et al. A defect in circulating mononuclear phagocytes in chronic granulomatous disease of childhood. J. Immunol. 101: 1093–1095, 1968.PubMedGoogle Scholar
  92. 92.
    Van Furth, R., Cohn, Z. A. The origin and kinetics of mononuclear phagocytes. J. Exp. Med. 128: 415–435, 1968.PubMedGoogle Scholar
  93. 93.
    Moellering, R. C., Jr., Weinberg, A. N. Persistent salmonella infection in a female carrier for chronic granulomatous disease. Ann. Intern. Med. 73: 595–601, 1970.PubMedGoogle Scholar
  94. 94.
    Barker, L. F., Sladen, F. J. A small epidemic of jaundice with symptoms of gastrointestinal catarrh. Bull. Johns Hopkins Hosp. 20: 310–314, 1909.Google Scholar
  95. 95.
    Han, T., Sokal, J. E., Neter, E. Salmonellosis in disseminated malignant diseases: A seven–year review (1959–1965). N. Engl. J. Med. 276: 1045–1052, 1967.PubMedGoogle Scholar
  96. 96.
    Shechmeister, I. L., Paulissen, L. J., Fishman, M. Sublethal total body x–radiation and susceptibility of mice to Salmonella enteritidis and Escherichia coli. Proc. Soc. Exp. Biol. Med. 83: 205–209, 1953.PubMedGoogle Scholar
  97. 97.
    Bowen, S. T., Gowen, J. W., Tauber, O. E. Cortisone and mortality in mouse typhoid: 1. Effect of hormone dosage and times of injection. Proc. Soc. Exp. Biol. Med. 94: 476479, 1957.Google Scholar
  98. 98.
    Hammond, C. W., Tompkins, M., Miller, C. P. Occurrence of generalized infection of enteric origin in mice poisoned with nitrogen mustard. Proc. Soc. Exp. Biol. Med. 82: 137–140, 1953.PubMedGoogle Scholar
  99. 99.
    Lewis, J. F., Warshauer, S. E. Mycotic aneurysm of the abdominal aorta: A case due to Salmonella cholerae–suis var. Kunzendorf. South. Med. J. 62: 597–598, 1969.Google Scholar
  100. 100.
    Kanwar, Y. S., Malhotra, V., Andersen, B. R., et al. Salmonellosis associated with abdominal aortic aneurysm. Arch. Intern. Med. 134: 1095–1098, 1974.PubMedGoogle Scholar
  101. 101.
    Ten Eyck, F. W., Wellman, W. E. Salmonellosis associated with abdominal aortic aneurysm and edema of lower extremities: A case report. Postgrad. Med. 26: 334–339, 1959.Google Scholar
  102. 102.
    Zak, F. G., Strauss, L., Saphra, I. Rupture of diseased large arteries in the course of enterobacterial (salmonella) infections. N. Engl. J. Med. 258: 824–828, 1958.PubMedGoogle Scholar
  103. 103.
    Dixon, R. H., Lowicki, E. M. Salmonellosis associated with abdominal aortic aneurysm. South. Med. J. 59: 1403, 1408, 1966.Google Scholar
  104. 104.
    Crane, A. R. Primary multilocular mycotic aneurysm in the aorta. Arch. Pathol. 24: 634–641, 1937.Google Scholar
  105. 105.
    Dehlinger, K. R. Salmonella osteomyelitis of the spine associated with abdominal aortic aneurysm: Report of a case. N. Engl. J. Med. 238: 728–732, 1948.Google Scholar
  106. 106.
    Teixerira, R. Typhoid fever of protracted course. Rev. Inst. Med. Trop. Sao. Paulo 2: 56–70, 1960.Google Scholar
  107. 107.
    Tai, T. Y., Hsu, C. Y., Chang, H. C., et al. Typhoid and paratyphoid fevers occurring in cases of schistosomiasis. Chin. Med. J. 76: 426–435, 1958.PubMedGoogle Scholar
  108. 108.
    Neves, J., Martins, N. R. Long duration of septicaemic salmonellosis: 35 cases with 12 implicated species of salmonella. Trans. Soc. Trop. Med. Hyg. 61: 541–552, 1967.Google Scholar
  109. 109.
    Rocha, H., Kirk, J. W., Hearey, C. D., Jr. Prolonged Salmonella bacteremia in patients with Schistosoma mansoni infection. Arch. Intern. Med. 128: 254–257, 1971.PubMedGoogle Scholar
  110. 110.
    Rocha, H., Magnavita, M., Teles, E. da S., et al. Atividade antibacteriana do s6ro de pacientes com forma hepatesplénica de esquistóssomose mansônica. Rev. Inst. Med. Trop. Säo Paulo 10: 364–370, 1968.PubMedGoogle Scholar
  111. 111.
    Fernandes, D. J., Rocha, H. Caracteristicas de reacâo inflamatória em pacientes corn forma hepatesplénica da esquistóssomose mans6nica e calazar. Rev. Inst. Med. Trop. Sao Paulo 9: 129–134, 1967.PubMedGoogle Scholar
  112. 112.
    Ottens, H., Dickerson, G. Bacterial invasion of schistosomes. Nature (London) 223: 506–507, 1969.Google Scholar
  113. 113.
    Biological control of schistosomiasis? Lancet 2:477–478, 1969.Google Scholar
  114. 114.
    Neves, J., Marinho, R. P., Martins, N. R. L. L. Prolonged septicemic salmonellosis: Treatment of intercurrent schistosomiasis with niridazole. Trans. R. Soc. Trop. Med. Hyg. 63: 79–84, 1969.Google Scholar
  115. 115.
    Lindeman, R. J., Weinstein, L., Levitan, R., et al. Ulcerative colitis and intestinal salmonellosis. Am. J. Med. Sci. 254: 855–861, 1967.PubMedGoogle Scholar
  116. 116.
    Dronfield, M. W., Fletcher, J., Langman, M. J. S. Coincident salmonella infections and ulcerative colitis: Problems of recognition and management. Br. Med. J. 1: 99–100, 1974.PubMedGoogle Scholar
  117. 117.
    Gilman, R. H., Terminel, M., Levine, M. M., et al. Relative efficacy of blood, urine, rectal swab, bone–marrow, and rose–spot cultures for recovery of Salmonella typhi in typhoid fever. Lancet 1: 1211–1213, 1975.PubMedGoogle Scholar
  118. 118.
    Robertson, R. P., Abdel Wahab, M. F. A. Influence of chloramphenicol and ampicillin on antibody response in typhoid–paratyphoid fever. Ann. Intern. Med. 72: 219–221, 1970.PubMedGoogle Scholar
  119. 119.
    Kobland, J. D., Gustafson, R. H., Langner, P. H. Antibiotic sensitivity of Salmonella isolated from healthy market hogs (abstract No. A57). In Abstracts of the Annual Meeting of the American Society for Microbiology, Atlantic City, N.J., May 7, 1976.Google Scholar
  120. 120.
    Siegel, D., Huber, W. G., Enloe, F. Continuous non–therapeutic use of antibacterial drugs in feed and drug resistance of the gram–negative enteric florae of food–producing animals. Antimicrob. Agents Chemother. 6: 697–701, 1974.PubMedGoogle Scholar
  121. 121.
    Guinée, P., Ugueto, N., VanLeeuwen, N. Escherichia coli with resistance factors in vegetarians, babies, and nonvegetarians. Appl. Microbiol. 20: 531–535, 1970.PubMedGoogle Scholar
  122. 122.
    Timoney, J. F. The epidemiology and genetics of antibiotic resistance of Salmonella typhimurium isolated from diseased animals in New York. J. Infect. Dis. 137: 67–73, 1978.PubMedGoogle Scholar
  123. 123.
    Levy, S. B., Fitzgerald, G. B., Macone, A. B. Changes in intestinal flora of farm personnel after introduction of a tetracycline–supplemented feed on a farm. N. Engl. J. Med. 295: 583–588, 1976.PubMedGoogle Scholar
  124. 124.
    Anderson, E. S., Lewis, M. J. Drug resistance and its transfer in Salmonella typhimurium. Nature 206: 579–583, 1965.PubMedGoogle Scholar
  125. 125.
    United States Department of Health, Education and Welfare, Center for Disease Control. Morbid. Mortal. Week. Rep., July 22, 1977.Google Scholar
  126. 126.
    Marx, M. B. The effect of interspecies contact upon diarrhea morbidity and salmonellosis in children. J. Infect. Dis. 120: 202–209, 1969.PubMedGoogle Scholar
  127. 127.
    Neu, H. C., Winshell, E. B., Winter, J., et al. Antibiotic resistance of Salmonella in the northeastern United States 1968–1969. N.Y. State J. Med. 71: 1196–1200, 1971.PubMedGoogle Scholar
  128. 128.
    Neu, H. C., Cherubin, C. E., Longo, E. D., et al. Antimicrobial resistance and R–factor transfer among isolates of Salmonella in the northeastern United States: A comparison of human and animal isolates. J. Infect. Dis. 132: 617–622, 1975.PubMedGoogle Scholar
  129. 129.
    Finland, M., Garner, C., Wilcox, C., et al. Salmonellosis and shigellosis at Boston City Hospital: Part 2. Susceptibility of strains of salmonellae and shigellae to antibacterial agents. J. Am. Med. Assoc. 229: 1309–1312, 1974.Google Scholar
  130. 130.
    Pocurull, D. W., Gaines, S. A., Mercer, H. D. Survey of infectious multiple drug resistance among Salmonella isolated from animals in the United States. Appl. Microbiol. 21: 358–362, 1971.Google Scholar
  131. 131.
    Anderson, E. S., Threlfall, E. J. The characterization of plasmids in the enterobacteria. J. Hyg. (Cambridge) 72: 47I–487, 1974.Google Scholar
  132. 132.
    Hariharan, H., Barnum, D. A., Mitchell, W. R. Drug resistance among pathogenic bacteria from animals in Ontario. Can. J. Comp. Med. 38: 213–221, 1974.PubMedGoogle Scholar
  133. 133.
    Grant, R. B., Bannatyne, R. M., Shapley, A. J. Resistance to chloramphenicol and ampicillin of Salmonella typhimurium in Ontario, Canada. J. Infect. Dis. 134: 354–361, 1976.PubMedGoogle Scholar
  134. 134.
    Saad, A. F., Farrar, W. E. Antimicrobial resistance and R factors in Salmonella isolated from humans and animals in Georgia and South Carolina. South. Med. J. 70: 305–308, 1977.PubMedGoogle Scholar
  135. 135.
    Smith, H. W. Thermosensitive transfer factors in chloramphenicol–resistant strains of Salmonella typhi. Lancet 2: 281–282, 1974.PubMedGoogle Scholar
  136. 136.
    Anderson, E. S. The problem and implications of chloramphenicol resistance in the typhoid bacillus. J. Hyg. (Cambridge) 74: 289–299, 1975.Google Scholar
  137. 137.
    Smith, H. W. Transfer of antibiotic resistance from animal and human strains of Escherichia coli to resident E. coli in the alimentary tract of man, Lancet 1: 1174–1176, 1969.PubMedGoogle Scholar
  138. 138.
    Fison, D. C., Singer, E. Treatment of gastro–enteritis in infants with “chloromycetin.” Med. J. Aust. 2: 957–959, 1950.PubMedGoogle Scholar
  139. 139.
    Macdonald, W. B., Friday, F., McEacharn, M. The effect of chloramphenicol in Salmonella enteritis of infancy. Arch. Dis. Child. 29: 238–241, 1954.PubMedGoogle Scholar
  140. 140.
    Rosenstein, B. J. Salmonellosis in infants and children: Epidemiologic and therapeutic considerations. J. Pediatr. 70: 1–7, 1967.Google Scholar
  141. 141.
    Rosenthal, S. J. Exacerbation of Salmonella enteritis due to ampicillin. N. Engl. J. Med. 280: 147–148, 1969.PubMedGoogle Scholar
  142. 142.
    Miinnich, D. The treatment of salmonellosis with trimethoprim/sulphamethoxazole and their combination with polymyxin B in adult patients. Chemotherapy (Basel), 18: 119–129, 1973.Google Scholar
  143. 143.
    Geddes, A. M., Fothergill, R., Goodall, J. A. D., et al. Evaluation of trimethoprimsulphamethoxazole compound in treatment of salmonella infections. Br. Med. J. 3: 451–454, 1971.PubMedGoogle Scholar
  144. 144.
    Kazemi, M., Gumpert, T. G., Marks, M. I. A controlled trial comparing sulfamethoxazole–trimethoprim, ampicillin, and no therapy in the treatment of Salmonella gastroenteritis in children. J. Pediatr. 83: 646–650, 1973.PubMedGoogle Scholar
  145. 145.
    Dawkins, A. T., Jr., Hornick, R. B. Evaluation of antibiotics in a typhoid model. Antimicrob. Agents Chemother. –1966, 6–10, 1967.Google Scholar
  146. 146.
    Olarte, J., Galindo, E. Salmonella typhi resistant to chloramphenicol, ampicillin, and other antimicrobial agents: Strains isolated during an extensive typhoid fever epidemic in Mexico. Antimicrob. Agents Chemother. 4: 597–601, 1973.PubMedGoogle Scholar
  147. 147.
    Vazquez, V., Calderón, E., Rodriguez, R. S. Chloramphenicol–resistant strains of Salmonella typhosa. N. Engl. J. Med. 286: 1220, 1972.PubMedGoogle Scholar
  148. 148.
    Brown, J. D., Mo, D. H., Rhoades, E. R. Chloramphenicol–resistant Salmonella typhi in Saigon. J. Am. Med. Assoc. 231: 162–166, 1975.Google Scholar
  149. 149.
    Lawrence, R. M., Goldstein, E., Hoeprich, P. D. Typhoid fever caused by chloramphenicol–resistant organisms. J. Am. Med. Assoc. 224: 861–863, 1973.Google Scholar
  150. 150.
    Overturf, G., Marton, K. I., Mathies, A. W., Jr. Antibiotic resistance in typhoid fever: Chloramphenicol resistance among clinical isolates of Salmonella typhosa in Los Angeles, 1972—epidemiologic and bacteriologic characteristics. N. Engl. J. Med. 280: 463–465, 1973.Google Scholar
  151. 151.
    Paramasivan, C. N., Subramanian, S., Shanmugasundaram, N. Antimicrobial resistance and incidence of R factor among Salmonella isolated from patients with enteric fever and other clinical conditions in Madras, India (1975–1976). J. Infect. Dis. 136: 796–800, 1977.PubMedGoogle Scholar
  152. 152.
    Woodward, T. E., Smadel, J. E., Ley, H. L., Jr., et al. Preliminary report on the beneficial effect of chloromycetin in the treatment of typhoid fever. Ann. Intern. Med. 29: 131–134, 1948.PubMedGoogle Scholar
  153. 153.
    Dammermann, R., Freitag, V. Die Behandlung des Typhos abdominalis mit Trimethoprim–Sulfamethoxazol. Dtsch. Med. Wochenschr. 98: 1251–1253, 1973.PubMedGoogle Scholar
  154. 154.
    Stamps, T. J., Wicks, A. C. B. Trimethoprim–sulphamethoxazole (Bactrim) in the treatment of typhoid fever. S. Afr. Med. J. 46: 652–655, 1972.PubMedGoogle Scholar
  155. 155.
    Farid, Z., Hassan, A., Wahab, M. F. A., et al. Trimethoprim–sulphamethoxazole in enteric fevers. Br. Med. J. 3: 323–324, 1970.PubMedGoogle Scholar
  156. 156.
    Kamat, S. A. Evaluation of therapeutic efficacy of trimethoprim–sulphamethoxazole and chloramphenicol in enteric fever. Br. Med. J. 3: 320–322, 1970.PubMedGoogle Scholar
  157. 157.
    Gutiérrez, G., Serafin, F., Sanchez, R. Evaluación de cuatro antimicrobianos en el tratamiento de tifoidea por Salmonella typhi resistente a chloramfénicol. Bol. Méd. Hosp. Infant. Méx. (Span. Ed.) 31: 597–606, 1974.Google Scholar
  158. 158.
    Salcedo, M., Borgoilo, J. M., Greiber, R., et al. Tratamiento de la fiebre tifoidea y paratifus con trimétoprim y sulfametxazol. Rev. Méd. Chile 100: 1064–1067, 1972.PubMedGoogle Scholar
  159. 159.
    Snyder, M. J., Perroni, J., Gonzalez, O., et al. Trimethoprim–sulfamethoxazole in the treatment of typhoid and paratyphoid fevers. J. Infect. Dis. 128: S734–S737, 1973.Google Scholar
  160. 160.
    Sardesai, H. V., Karandikar, R. S., Harshe, R. G. Comparative trial of cotrimoxazole and chloramphenicol in typhoid fever. Br. Med. J. 1: 82–83, 1973.PubMedGoogle Scholar
  161. 161.
    Hassan, A., Hathout, S., Safwat, Y., et al. A comparative evaluation of the treatment of typhoid fevers with co–trimoxazole and chloramphenicol in Egypt. J. Trop. Med. Hyg. 78: 50–53, 1975.PubMedGoogle Scholar
  162. 162.
    Gilman, R. H., Terminel, M., Levine, M. M., et al. Comparison of trimethoprimsulfamethoxazole and amoxicillin in therapy of chloramphenicol–resistant and chloramphenicol–sensitive typhoid fever. J. Infect. Dis. 132: 630–6636, 1975.PubMedGoogle Scholar
  163. 163.
    Farid, Z., Bassily, S., Mikhail, I. A., et al. Treatment of chronic enteric fever with amoxicillin. J. Infect. Dis. 132: 698–701, 1975.PubMedGoogle Scholar
  164. 164.
    Scragg, J. N., Rubidge, C. J. Amoxycillin in the treatment of typhoid fever in children. Am. J. Trop. Med. Hyg. 24: 860–865, 1975.PubMedGoogle Scholar
  165. 165.
    Scragg, J. N. Further experience with amoxycillin in typhoid fever in children. Br. Med. J. 2: 1031–1033, 1976.Google Scholar
  166. 166.
    Hoffman, T. A., Ruiz, C. J., Counts, G. W., et al. Waterborne typhoid fever in Dade County, Florida: Clinical and therapeutic evaluation of 105 bacteremic patients. Am. J. Med. 59: 481–487, 1975.PubMedGoogle Scholar
  167. 167.
    Robertson, R. P., Wahab, M. F. A., Raasch, F. O. Evaluation of chloramphenicol and ampicillin in salmonella enteric fever. N. Engl. J. Med. 278: 171–176, 1968.Google Scholar
  168. 168.
    Hardy, G., Padfield, C. J., Chadwick, P., et al. Typhoid outbreak in Kingston, Ontario: Experience with high–dose oral ampicillin. Can. Med. Assoc. J. 116: 761–764, 767, 1977.Google Scholar
  169. 169.
    Mikhail, I. A., Kent, D. C., Sorensen, K., et al. Concentrations of ampicillin and chloramphenicol in the serum of patients with acute salmonella enteric fever. Antimicrob. Agents Chemother. 2: 336–339, 1972.PubMedGoogle Scholar
  170. 170.
    DuPont, H. L., Hornick, R. B., Weiss, C. F., et al. Evaluation of chloramphenicol acid succinate therapy of induced typhoid fever and Rocky Mountain spotted fever. N. Engl. J. Med. 282: 53–57, 1970.PubMedGoogle Scholar
  171. 171.
    Pickering, L. K., Hoecker, J. L., Kramer, W. G., et al. Clinical pharmacology of two chloramphenicol preparations in children: Sodium succinate (IV) and palmitate (oral) esters. J. Pediatr. 96: 757–761, 1980.PubMedGoogle Scholar
  172. 172.
    Main, R. G. Treatment of the chronic alimentary enteric carrier. Br. Med. J. 1: 328–333, 1961.Google Scholar
  173. 173.
    Jersild, T., Neukirch, E., Raun, J., et al. Typhoid carriers treated with high dosages of penicillin. Antibiot. Med. 6: 292–294, 1959.PubMedGoogle Scholar
  174. 174.
    Perkins, J. C., Devetski, R. L., Dowling, H. F. Ampicillin in the treatment of Salmonella carriers. Arch. Intern. Med. 118: 528–533, 1966.PubMedGoogle Scholar
  175. 175.
    Dinbar, A., Altmann, G., Tulcinsky, D. B. The treatment of chronic biliary salmonella carriers. Am. J. Med. 47: 236–242, 1969.PubMedGoogle Scholar
  176. 176.
    Simon, H. J., Miller, R. C. Ampicillin in the treatment of chronic typhoid carriers: Report on fifteen treated cases and a review of the literature. N. Engl. J. Med. 274: 807815, 1966.Google Scholar
  177. 177.
    Phillips, W. E. Treatment of chronic typhoid carriers with ampicillin. J. Am. Med. Assoc. 217: 913–915, 1971.Google Scholar
  178. 178.
    Johnson, W. D., Jr., Hook, E. W., Lindsey, E., et al. Treatment of chronic typhoid carriers with ampicillin. Antimicrob. Agents Chemother. 3: 439–440, 1973.PubMedGoogle Scholar
  179. 179.
    Scioli, C., Fiorentino, F., Sasso, G. Treatment of Salmonella typhi carriers with intravenous ampicillin. J. Infect. Dis. 125: 170–173, 1972.PubMedGoogle Scholar
  180. 180.
    Nolan, C. M., White, P. C., Jr. Treatment of typhoid carriers with amoxicillin: Correlates of successful therapy. J. Am. Med. Assoc. 239: 2352–2354, 1978.Google Scholar
  181. 181.
    Brodie, J., Macqueen, I. A., Livingstone, D. Effect of trimethoprim–sulphamethoxazole on typhoid and salmonella carriers. Br. Med. J. 3: 318–319, 1970.PubMedGoogle Scholar
  182. 182.
    Clementi, K. J. Treatment of Salmonella carriers with trimethoprim–sulfamethoxazole. Can. Med. Assoc. J. 122 (Spec. No. 13): 28–32, 1975.Google Scholar
  183. 183.
    Freerksen, E., Rosenfeld, M., Freerksen, R., et al. Treatment of chronic salmonella carriers: Study with 40 cases of S. typhi, 19 cases of S. paratyphi B and 28 cases of S. enteritidis strains. Chemotherapy 23: 192–210, 1977.PubMedGoogle Scholar
  184. 184.
    Nolan, C. M., White, P. C. Treatment of typhoid carriers with amoxicillin. J. Am. Med. Assoc. 239: 2352–2354, 1978.Google Scholar
  185. 185.
    Benenson, A. S. Serological responses of man to typhoid vaccines. Bull. W.H.O. 30: 653–662, 1964.PubMedGoogle Scholar
  186. 186.
    Mackaness, G. B., Blanden, R. V., Collins, F. M. Host–parasite relations in mouse typhoid. J. Exp. Med. 124: 573–583, 1966.PubMedGoogle Scholar
  187. 187.
    Ushiba, D. Two types of immunity in experimental typhoid: “Cellular immunity” and “humoral immunity.” Keio J. Med. 14: 45–61, 1965.Google Scholar
  188. 188.
    Mackaness, G. B. Resistance to intracellular infection. J. Infect. Dis. 123: 439–445, 1971.PubMedGoogle Scholar
  189. 189.
    Collins, F. M. Effect of specific immune mouse serum on the growth of Salmonella enteritidis in mice preimmunized with living or ethyl alcohol–killed vaccines. J. Bacteriol. 97: 676–683, 1969.PubMedGoogle Scholar
  190. 190.
    Marmion, D. E., Naylor, G. R. E., Stewart, I. O. Second attacks of typhoid fever. J. Hyg. (London) 51: 260–267, 1953.Google Scholar
  191. 191.
    DuPont, H. L., Hornick, R. B., Snyder, M. J., et al. Studies of immunity in typhoid fever: Protection induced by killed oral antigens or by primary infection. Bull. W.H.O. 44: 667–6672, 1971.PubMedGoogle Scholar
  192. 192.
    Cvjetanovié, B., Uemura, K. The present status of field and laboratory studies of typhoid and paratyphoid vaccines: With special reference to studies sponsored by the World Health Organization. Bull. W.H.O. 32: 29–36, 1965.Google Scholar
  193. 193.
    Hejfec, L. B., Salmin, M. Z., Lejtman, M. L., et al. A controlled field trial and laboratory study of five typhoid vaccines in the USSR. Bull. W.H.O. 34: 321–339, 1966.PubMedGoogle Scholar
  194. 194.
    Ashcroft, M. T., Singh, B., Nicholson, C. C., et al. A seven–year field trial of two typhoid vaccines in Guyana. Lancet 2: 1056–1059, 1967.PubMedGoogle Scholar
  195. 195.
    Hejfec, L. B., Levina, L. A., Kuzminova, M. L., et al. A controlled field trial to evaluate the protective capacity of a single dose of acetone–killed agar–grown and heat–killed broth–grown typhoid vaccines. Bull. W.H.O. 40: 903–907, 1969.PubMedGoogle Scholar
  196. 196.
    Hejfec, L. B., Levina, L. A., Kuzminova, M. L., et al. Controlled field trial with dried sorbed parathyphoid B and typhoid vaccines. Bull. W.H.O. 45: 787–794, 1971.PubMedGoogle Scholar
  197. 197.
    Spaun, J., Uemura, K. International reference preparations of typhoid vaccine: A report on international collaborative laboratory studies. Bull. W.H.O. 31: 761–791, 1964.PubMedGoogle Scholar
  198. 198.
    Pittman, M., Bohner, H. J. Laboratory assays of different types of field trial typhoid vaccines and relationship to efficacy in man. J. Bacteriol. 91: 1713–1723, 1966.PubMedGoogle Scholar
  199. 199.
    Wong, K. H., Feeley, J. C., Pittman, M., et al. Adhesion of Vi antigen and toxicity in typhoid vaccines inactivated by acetone or by heat and phenol. J. Infect. Dis. 129: 50 1506, 1974.Google Scholar
  200. 200.
    Wong, K. H., Feeley, J. C., Northrup, R. S., et al. Vi antigen from Salmonella typhosa and immunity against typhoid fever: 1. Isolation and immunologic properties in animals. Infect. Immun. 9: 348–353, 1974.PubMedGoogle Scholar
  201. 201.
    Levin, D. M., Wong, K. H., Reynolds, H. Y., et al. Vi antigen from Salmonella typhosa and immunity against typhoid fever: II. Safety and antigenicity in humans. Infect. Immun. 12: 1290–1294, 1975.PubMedGoogle Scholar
  202. 202.
    Landy, M. Studies on Vi antigen: VI. Immunization of human beings with purified Vi antigen. Am. J. Hyg. 60: 52–62, 1954.Google Scholar
  203. 203.
    Diena, B. B., Ryan, A., Wallace, R., et al. Ineffectiveness of Vi and chemically treated endotoxins as typhoid vaccines in mice challenged with a Salmonella typhosa–Salmonella typhimurium hybrid. Infect. Immun. 12: 1470–1471, 1975.PubMedGoogle Scholar
  204. 204.
    Venneman, M. R. Purification of immunogenically active ribonucleic acid preparations of Salmonella typhimurium: Molecular–sieve and anion–exchange chromatography. Infect. Immun. 5: 269–282, 1972.Google Scholar
  205. 205.
    Angerman, C. R., Eisenstein, T. K. Comparative efficacy and toxicity of a ribosomal vaccine, acetone–killed cells, lipopolysaccharide, and a live cell vaccine prepared from Salmonella typhimurium. Infect. Immun. 19: 575–582, 1978.PubMedGoogle Scholar
  206. 206.
    Venneman, M. R., Berry, L. J. Cell–mediated resistance induced with immunogenic preparations of Salmonella typhimurium. Infect. Immun. 4: 381–387, 1971.PubMedGoogle Scholar
  207. 207.
    Smith, R. A., Bigley, N. J. Detection of delayed hypersensitivity in mice injected with ribonucleic acid–protein fractions of Salmonella typhimurium. Infect. Immun. 6: 384–389, 1972.PubMedGoogle Scholar
  208. 208.
    Johnson, W., Ribosomal vaccines: II. Specificity of the immune response to ribosomal ribonucleic acid and protein isolated from Salmonella typhimurium. Infect. Immun. 8: 395–400, 1973.PubMedGoogle Scholar
  209. 209.
    Eisenstein, T. K. Evidence for O antigens as the antigenic determinants in “ribosomal” vaccines prepared from Salmonella. Infect. Immun. 12: 364–377, 1975.PubMedGoogle Scholar
  210. 210.
    Metchnikoff, E., Besredka, A. Recherches sur la fièvre typh6ide expérimentale. Ann. Inst. Pasteur Paris 25: 193–221, 1911.Google Scholar
  211. 211.
    Chuttani, C. S., Prakash, K., Vergese, A., et al. Effectiveness of oral killed typhoid vaccine. Bull. W.H.O. 45: 445–450, 1971.PubMedGoogle Scholar
  212. 212.
    Chuttani, C. S., Prakash, K., Vergese, A., et al. Ineffectiveness of an oral killed typhoid vaccine in a field trial. Bull. W. H.O. 48: 754–755, 1973.PubMedGoogle Scholar
  213. 213.
    Kiefer, W., Gransow, P., Schmidt, G., et al. Salmonellosis in mice: Immunization experiments with Salmonella–Escherichia coli hybrids. Infect. Immun. 13: 1517–1518, 1976.PubMedGoogle Scholar
  214. 214.
    Diena, B. B., Ryan, A., Wallace, R., et al. Effectiveness of parenteral and oral typhoid vaccination in mice challenged with a Salmonella typhi–Salmonella typhimurium hybrid. Infect. Immun. 15: 997–998, 1977.PubMedGoogle Scholar
  215. 215.
    DuPont, H. L., Hornick, R. B., Snyder, M. J., et al. Immunity in typhoid fever: Evaluation of live streptomycin–dependent vaccine. Antimicrob. Agents Chemother. 10: 236–239, 1970.PubMedGoogle Scholar
  216. 216.
    Reitman, M. Infectivity and antigenicity of streptomycin–dependent Salmonella typhosa. J. Infect. Dis. 117: 101–107, 1967.PubMedGoogle Scholar
  217. 217.
    Cvjetanovie, B., Mel, D. M., Felsenfeld, O. Study of live typhoid vaccine in chimpanzees. Bull. W.H.O. 42: 449–507, 1970.Google Scholar
  218. 218.
    Germanier, R. Immunity in experimental salmonellosis: I. Protection induced by rough mutants of Salmonella typhimurium. Infect. Immun. 2: 309–315, 1970.Google Scholar
  219. 219.
    Germanier, R., Firer, E. Immunity in experimental salmonellosis: II. Basis for the avirulence and protective capacity of gal E mutants of Salmonella typhimurium. Infect. Immun. 4: 663–673, 1971.Google Scholar
  220. 220.
    Levine, M. M., DuPont, H. L., Hornick, R. B., et al. Attenuated, streptomycin–dependent Salmonella typhi oral vaccine: Potential deleterious effects of lyophilization. J. Infect. Dis. 133: 424–429, 1976.PubMedGoogle Scholar
  221. 221.
    Fahey, K. J., Cooper, G. N. Oral immunization against experimental salmonellosis: I. Development of temperature–sensitive mutant vaccines. Infect. Immun. 1: 263–270, 1970.PubMedGoogle Scholar
  222. 222.
    Fahey, K. J., Cooper, G. N. Oral immunization in experimental salmonellosis: II. Characteristics of the immune response to temperature–sensitive mutants given by oral and parenteral routes. Infect. Immun. 2: 183–191, 1970.PubMedGoogle Scholar
  223. 223.
    Vladoianu, I. R., Dubini, R., Bolloli, A. Contribution to the study of live streptomycin–dependent salmonella vaccines: The problem of reversion to a virulent form. J. Hyg. (Cambridge) 75: 203–214, 1975.Google Scholar
  224. 224.
    Fukasawa, T., Nikaido, H. Galactose–sensitive mutants of Salmonella: II. Bacteriolysis induced by galactose. Biochim. Biophys. Acta 48:470–483, 1%1.Google Scholar
  225. 225.
    Gilman, R. H., Hornick, R. B., Woodward, W. E., et al. Evaluation of 2 UDPglucose–4–epimeraseless mutant of Salmonella typhi as a live oral vaccine. J. Infect. Dis. 136: 717–723, 1977.PubMedGoogle Scholar
  226. 226.
    DuPont, H. L. Recent developments in immunization against diarrhea diseases. South. Med. J. 68: 1027–1034, 1975.PubMedGoogle Scholar

Copyright information

© Plenum Publishing Corporation 1980

Authors and Affiliations

  • Herbert L. DuPont
    • 1
  • Larry K. Pickering
    • 2
  1. 1.Program in Infectious Diseases and Clinical MicrobiologyThe University of Texas Health Science Center Medical SchoolHoustonUSA
  2. 2.Pediatric Infectious Diseases Program in Infectious Diseases and Clinical MicrobiologyThe University of Texas Health Science Center Medical SchoolHoustonUSA

Personalised recommendations